Extracorporeal membrane oxygenation without systemic anticoagulation: a case-series in challenging conditions
Extracorporeal membrane oxygenation (ECMO) use in patients with active bleedings or traumatic injuries may be challenging because of the risk of refractory haemorrhage related to systemic anticoagulation (SA). Technological advancements, especially heparin coated circuits, allowed ECMO application w...
Saved in:
Published in | Journal of thoracic disease Vol. 12; no. 5; pp. 2113 - 2119 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
AME Publishing Company
01.05.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 2072-1439 2077-6624 |
DOI | 10.21037/jtd.2020.04.54 |
Cover
Summary: | Extracorporeal membrane oxygenation (ECMO) use in patients with active bleedings or traumatic injuries may be challenging because of the risk of refractory haemorrhage related to systemic anticoagulation (SA). Technological advancements, especially heparin coated circuits, allowed ECMO application with a mild or no anticoagulation regimen in some circumstances. We herein report a limited case-series of ECMO application without anticoagulation.
ECMO without SA was established in 6 patients. Four of them received veno-arterial mode. Full heparin antagonization with protamine was provided in 3 post-cardiotomy cases. Tip-to-tip heparin-coated ECMO circuit was used in 4 patients, whereas heparin-coated tubing and no heparin-coated cannulas were applied for the remaining subjects.
Mean duration of support and pump flow were 10±4 hours and 3.0±0.7 litres respectively. No ECMO related complication or oxygenator failure occurred, nor was clotting of the circuit observed at inspection. All patients were weaned from ECMO and half of them survived and were discharged.
Short ECMO duration without anticoagulation was feasible and provided effective cardiopulmonary support in patients with active bleeding or high hemorrhagic risk. Further investigations are needed to evaluate its benefits or limitations for a protracted time, in a wider range of clinical conditions and in larger patient populations. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributions: (I) Conception and design: D Fina, M Ranucci, R Lorusso; (II) Administrative support: R Lorusso; (III) Provision of study materials or patients: D Fina, R Lorusso; (IV) Collection and assembly of data: D Fina, M Matteucci, F Jiritano; (V) Data analysis and interpretation: P Meani, A Ballotta, M Kowalewski; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. |
ISSN: | 2072-1439 2077-6624 |
DOI: | 10.21037/jtd.2020.04.54 |